Page 24 - IMO-2-2

Innovative Medicines & Omics Pharmacotherapy of obesity

doi: 10.1016/j.eclinm.2022.101436 doi: 10.1007/s13679-019-00335-3
68. Christou GA, Kiortsis DN. The efficacy and safety of the 79. Kanto K, Ito H, Noso S, et al. Effects of dosage and dosing
naltrexone/bupropion combination for the treatment of frequency on the efficacy and safety of high-dose metformin
obesity: An update. Hormones. 2015;14(3):370-375. in Japanese patients with type 2 diabetes mellitus. J Diabetes
doi: 10.14310/horm.2002.1600 Investig. 2018;9(3):587-593.
69. Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, doi: 10.1111/jdi.12755
Gueorguieva R. Naltrexone-bupropion and behavior 80. Tarry-Adkins JL, Grant ID, Ozanne SE, Reynolds RM,
therapy, alone and combined, for binge-eating disorder: Aiken CE. Efficacy and side effect profile of different
Randomized double-blind placebo-controlled trial. Am J formulations of metformin: A systematic review and meta-
Psychiatry. 2022;179(12):927-937. analysis. Diabetes Ther 2021;12(7):1901-1914.
doi: 10.1176/appi.ajp.20220267 doi: 10.1007/s13300-021-01058-2
70. Vlachou M, Siamidi A, Protopapa C, Sotiropoulou I. 81. Seifarth C, Schehler B, Schneider HJ. Effectiveness of
A review on the colours, flavours and shapes used in metformin on weight loss in non-diabetic individuals with
paediatric 3D printed oral solid dosage forms. RPS Pharm obesity. Exp Clin Endocrinol Diabetes. 2013;121(1):27-31.
Pharmacol Rep. 2023;2(2):1-11. doi: 10.1055/s-0032-1327734
doi: 10.1093/rpsppr/rqad009 82. Talenezhad N, Mohammadi M, Ramezani-Jolfaie N,
71. Protopapa C, Siamidi A, Junqueira LA, et al. Sustained Mozaffari-Khosravi H, Salehi-Abargouei A. Effects of
release of 3D printed bupropion hydrochloride tablets l-carnitine supplementation on weight loss and body
bearing Braille imprints for the visually impaired. Int J composition: A systematic review and meta-analysis of 37
Pharm. 2024;663:124594. randomized controlled clinical trials with dose-response
analysis. Clin Nutr ESPEN. 2020;37:9-23.
doi: 10.1016/j.ijpharm.2024.124594
doi: 10.1016/J.CLNESP.2020.03.008
72. Milos G, Antel J, Kaufmann LK, et al. Short-term metreleptin
treatment of patients with anorexia nervosa: Rapid on-set 83. Batsis JA, Apolzan JW, Bagley PJ, et al. A systematic review of
of beneficial cognitive, emotional, and behavioral effects. dietary supplements and alternative therapies for weight loss
Transl Psychiatry. 2020;10:303. study importance. Obesity (Silver Spring). 2021;29:1102-1113.
doi: 10.1038/s41398-020-00977-1 doi: 10.1002/oby.23110
73. Barbosa BF, Aquino de Moraes FC, Barbosa CB, et al. 84. Phung HM, Jang D, Trinh TA, et al. Regulation of appetite-
A systematic review and meta-analysis. J Pers Med. related neuropeptides by Panax ginseng: A novel approach
2023;13:1460. for obesity treatment. J Ginseng Res. 2022;46(4):609-619.
doi: 10.3390/jpm13101460 doi: 10.1016/J.JGR.2022.03.007
74. Singh G, Krauthamer M, Bjalme-Evans M. Wegovy 85. Mohammadpour S, Amini MR, Shahinfar H, et al. Effects of
(Semaglutide): A new weight loss drug for chronic weight glucomannan supplementation on weight loss in overweight
management. J Investig Med. 2022;70(1):5-13. and obese adults: A systematic review and meta-analysis of
randomized controlled trials. Obes Med. 2020;19:100276.
doi: 10.1136/jim-2021-001952
doi: 10.1016/J.OBMED.2020.100276
75. Smits MM, Van Raalte DH. Safety of semaglutide. Front
Endocrinol (Lausanne). 2021;12:645563. 86. Song EJ, Rae Shin N, Jeon S, et al. Impact of the herbal
medicine, Ephedra sinica stapf, on gut microbiota and body
doi: 10.3389/fendo.2021.645563 weight in a diet-induced obesity model. Front Pharmacol.
76. Karagiannis T, Avgerinos I, Liakos A, et al. Management 2022;13:1042833.
of type 2 diabetes with the dual GIP/GLP-1 receptor doi: 10.3389/fphar.2022.1042833
agonist tirzepatide: A systematic review and meta-analysis.
Diabetologia. 2022;65:1251-1261. 87. Gibb RD, Sloan KJ, McRorie JW. Psyllium is a natural
nonfermented gel-forming fiber that is effective for weight
doi: 10.1007/s00125-022-05715-4/Published loss: A comprehensive review and meta-analysis. J Am Assoc
77. Rao K, Nimako EK. Adipose tissue, appetite, & Nurse Pract. 2023;35(8):468-476.
obesity SAT680 Mounjaro: A side effect. J Endocr Soc. doi: 10.1097/JXX.0000000000000882
2023;7:bvad114.
88. Vlachou M, Siamidi A, Anagnostopoulou D, et al. Tuning
doi: 10.1210/jendso/bvad114
the release of the pineal hormone melatonin via poly(ε-
78. Yerevanian A, Soukas AA. Metformin: Mechanisms in human caprolactone)-based copolymers matrix tablets. J Drug Deliv
obesity and weight loss. Curr Obes Rep. 2019;8(2):156-164. Sci Technol. 2023;79:104051.

Volume 2 Issue 2 (2025) 18 doi: 10.36922/imo.8316